Inhibikase Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| IKT | IMRX | AGMB | BBOT | VCRE | IVA | |
|---|---|---|---|---|---|---|
| Market cap | 218.37M | 243.51M | 337.35M | 184.40M | 265.87M | 914.17M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -3.7 | -3.0 | -3.4 | -0.8 | — | -5.2 |
| Price/book | 1.8 | 1.4 | 2.7 | 0.6 | — | 13.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −12.94% | −43.20% | −53.24% | −81.22% | −41.91% | −7.42% |
| Today | +5.74% | +2.17% | 0.00% | −0.86% | +1.18% | −3.97% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All IKT news ›Inhibikase Targets Investors Ahead of PAH Drug Development
WILMINGTON, DE — Inhibikase Therapeutics Inc. (Nasdaq: IKT) will meet with institutional investors at healthcare conferences in London and Florida during November and December 2026, as the clinical-stage pharmaceutical company advances…
Inhibikase Appoints Scott Wasserman to Board of Directors
Inhibikase Therapeutics ( (IKT) ) has issued an update. The most recent analyst rating on (IKT) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Inhibikase Therapeutics stock, see the IKT Stock…
More from 1 other outlet
Head-To-Head Survey: Inhibikase Therapeutics (NASDAQ:IKT) versus CorMedix (NASDAQ:CRMD)
Posted by Tristan Rich on Oct 10th, 2026 CorMedix (NASDAQ:CRMD – Get Free Report) and Inhibikase Therapeutics (NASDAQ:IKT – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- themarketsdaily.com2
- globenewswire.com1
- manilatimes.net1
- mychesco.com1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.